This information was released for public disclosure on April 16, 2013 at 3.00 pm CET. CellaVision today announced that the company and its partner Sysmex have co-developed a product which integrates ...

MUNDELEIN, Ill., July 20 Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced the addition of the CellaVision® DM1200 cell image analysis ...

Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year ...

CellaVision AB (CLVSF) achieved all-time high sales in the APAC region, demonstrating strong regional performance. The company reported a strong gross margin of 69%, attributed to a favorable product ...

Thank you very much, and thank you very much out there for dialing in for CellaVision's quarterly report Q4 2025, which obviously also includes the consolidated results from the entire 2025. A lot of ...

MUNDELEIN, Ill., July 27 Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis ...

Earnings call CellaVision reported Q4 2025 revenue of SEK 197 million, up 5.6% YoY (12.2% organic growth), with EBITDA margin of 33%, exceeding its 30% target. Strong momentum in the Americas offset ...

CellaVision achieved a 12.2% organic growth in Q4 2025. Stock price surged by 11.43% following the earnings release. EBITDA reached SEK 65 million, accounting for 33% of revenue. The company obtained ...

October 1 - December 31, 2023 Net sales increased by 32% (-7) to SEK 201 m (152). Sales increased organically by 29% (-17), currency effect 3% (10). EBITDA increased to SEK 73 m (48). EBITDA margin ...